Table 1.
Demographic data pH data and endoscopic results for patients before therapy with esomeprazole at baseline assessment
| |
Screening |
pH negative |
symptom relief 40 mg q.d. |
symptom relief 40 mg b.i.d. |
persistence |
|---|---|---|---|---|---|
| n = 31 | n = 9 | n = 19 | n = 2 | n = 1 | |
|
Gender (male/female) |
12/19 |
0/9 |
9/10 |
2/0 |
1/0 |
|
Age (mean±SD) |
52.4±17.1 years |
47.5±3.5 years |
52.5± 2.8 years |
23.7± 5.1 years |
66 years |
|
Endoscopy | |||||
| NERD |
|
7 (no erosions) |
7 |
|
|
| ERD Los Angeles A |
|
2 |
4 |
1 |
1 |
| ERD Los Angeles B |
|
|
5 |
1 |
|
| ERD Los Angeles C |
|
|
1 |
|
|
| Barrett’s Esophagus |
|
|
2 |
|
|
|
DeMeester score ±SD |
_ |
5.5 ± 1.8 |
26.9 ± 3.9 |
20.9 ± 15.7 |
30.3 |
| ‐ DeMeester [day 1] |
_ |
5.9 ± 2.9 |
28.2 ± 4.8 |
21.6 ± 19.8 |
23.2 |
| ‐ DeMeester [day 2] | _ | 4.9 ± 2.4 | 25.6 ± 3.9 | 10.7 ± 3.5 | 34.8 |